Experience

Davis Polk advised the sole placing agent for the placement of 56,200,000 new shares and 36,800,000 existing shares in Innovent Biologics, Inc., for an aggregate consideration of…

Davis Polk advised the representatives of the underwriters in an SEC-registered offering by Fifth Third Bancorp of 350,000 depositary shares, each representing a 1/25th ownership…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Lennox International Inc. of $300…

Davis Polk is advising Clarivate Plc on its approximately $6.8 billion combination with CPA Global. In the all-stock transaction, CPA Global shareholders will receive approximately 218…

Davis Polk advised Banco Votorantim S.A. in connection with the update of its global medium-term note program and offering thereunder of $500 million aggregate principal amount of 4.375%…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.5 billion of senior notes. The offering consisted of $650 million of 4.375% senior…

Davis Polk advised the dealer manager in connection with BRF S.A.’s offer to purchase for cash any and all of its 5.875% senior notes due 2022, 2.750% senior notes due 2022, 3.950%…

Davis Polk advised the underwriters in connection with an initial public offering of 11,000,000 shares of common stock of Nurix Therapeutics, Inc. at $19 per share, for total gross proceeds…

Davis Polk advised Pattern Energy Operations LP and Pattern Energy Operations Inc. on their Rule 144A/Regulation S offering of $700 million aggregate principal amount of 4.500% senior notes…

Davis Polk is advising EF Education First in connection with the proposed investment by Permira Funds in EF Kids & Teens business headquartered in Switzerland with schools in China and…